Published in
Wiley, Arthritis and Rheumatology, 4(72), p. 576-587, 2020
DOI: 10.1002/art.41134
Links
Tools
Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti–Tumor Necrosis Factor Treatments in Rheumatoid Arthritis
Journal article published in 2020 by
François Santinon,
Maxime Batignes 
,
Majda Lyna Mebrek,
Jerôme Biton,
Gaëlle Clavel,
Roxane Hervé,
Delphine Lemeiter,
Magali Breckler,
Florence Busato,
Jorg Tost ,
Marianne Ziol,
Marie‐Christophe Boissier,
Patrice Decker,
Luca Semerano,
Natacha Bessis
,
Majda Lyna Mebrek,
Jerôme Biton,
Gaëlle Clavel,
Roxane Hervé,
Delphine Lemeiter,
Magali Breckler,
Florence Busato,
Jorg Tost ,
Marianne Ziol,
Marie‐Christophe Boissier,
Patrice Decker,
Luca Semerano,
Natacha Bessis
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 